Chemoinformaics analysis of 1-(2,4,5-TRIMETHOXYPHENYL)PROPAN-1-ONE
| Molecular Weight | 224.256 | nRot | 5 |
| Heavy Atom Molecular Weight | 208.128 | nRig | 5 |
| Exact Molecular Weight | 224.105 | nRing | 1 |
| Solubility: LogS | -3.796 | nHRing | 0 |
| Solubility: LogP | 4.129 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 33.9167 |
| nHD | 0 | BPOL | 22.1273 |
| QED | 0.298 |
| Synth | 4.453 |
| Natural Product Likeliness | 2.359 |
| NR-PPAR-gamma | 0.765 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.002 |
| HIA | 0.586 |
| CACO-2 | -4.414 |
| MDCK | 0.0000263 |
| BBB | 0.057 |
| PPB | 1.00295 |
| VDSS | 2.011 |
| FU | 0.0152847 |
| CYP1A2-inh | 0.091 |
| CYP1A2-sub | 0.512 |
| CYP2c19-inh | 0.816 |
| CYP2c19-sub | 0.655 |
| CYP2c9-inh | 0.793 |
| CYP2c9-sub | 0.971 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.397 |
| CYP3a4-inh | 0.478 |
| CYP3a4-sub | 0.092 |
| CL | 8.74 |
| T12 | 0.201 |
| hERG | 0.004 |
| Ames | 0.467 |
| ROA | 0.883 |
| SkinSen | 0.891 |
| Carcinogencity | 0.43 |
| EI | 0.365 |
| Respiratory | 0.976 |
| NR-Aromatase | 0.937 |
| Antiviral | No |
| Prediction | 0.632663 |